Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-157.47%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 9.54Close
$ 5.09 - $ 94.02 52-Week Range
Ticker Information
Ticker
CNSPCompany Name
CNS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCNS PHARMACEUTICALS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CNSP - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -157.47% | $ -20.86M | $ 13.25M |
| 3/31/2025 | -153.54% | $ -17.17M | $ 11.18M |
| 12/31/2024 | -263.24% | $ -17.12M | $ 6.5M |
| 9/30/2024 | -419.12% | $ -14.18M | $ 3.38M |
| 6/30/2024 | 0% | $ -10.76M | $ -4.17M |
| 3/31/2024 | 0% | $ -12.51M | $ -4.22M |
| 12/31/2023 | 0% | $ -14.14M | $ -4.13M |
| 9/30/2023 | 0% | $ -13.91M | $ -1.7M |
| 6/30/2023 | -471.11% | $ -12.35M | $ 2.62M |
| 3/31/2023 | -325.57% | $ -12.31M | $ 3.78M |
Key Performance Insights, Last 5 Years
- CNS PHARMACEUTICALS INC's latest trailing twelve months (TTM) CROIC stands at -338.52%.
- Over the past 5 years, CNS PHARMACEUTICALS INC's average CROIC has been -194.58%.
- The median CROIC for CNS PHARMACEUTICALS INC during this period was -144.93%
- CNS PHARMACEUTICALS INC reached its highest CROIC over the past 5 years at -50.99%.
- The lowest CROIC recorded by CNS PHARMACEUTICALS INC in the same timeframe -471.11%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for CNS PHARMACEUTICALS INC is calculated as follows: FCF [ $ -8.38M ] / Inv. Capital [ $ 2.47M ]
(=) CROIC [ -338.52% ] CNSP - Cash Return on Invested Capital, Last 5 years
-471.11%
Minimum
Jun 30, 2023
-50.99%
Maximum
Dec 31, 2020
-194.58%
Average
-144.93%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.82% with a standard deviation of 15.01%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.3% |
| average | 2.82% |
| median | 5% |
| std | 15.01% |